ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

An Immunosenescence-Related Gene Signature to Evaluate the Prognosis, Immunotherapeutic Response, and Cisplatin Sensitivity of Bladder Cancer

Zhou, Ranran; Liang, Jingjing; Tian, Hu; Chen, Qi; Yang, Cheng; Liu, Cundong*南方医科大学
DISEASE MARKERS2022-3-2DOI: 10.1155/2022/2143892
2被引7阅读
引用收藏
分享

摘要

Immunosenescence refers to the immune system undergoing a series of degenerative changes with advancing age and is tightly associated with the initiation and progression of cancers. However, the immunosenescence-related genes as critical biomarkers for bladder cancer (BLCA) have not been systematically analyzed. We retrieved the immunosenescence-related genes from the public database and verified their association with hallmarks of immunosenescence based on The Cancer Genome Atlas (TCGA) cohort. Through gene pairing, Lasso, and univariate Cox regression, an 8-gene pair model was constructed to evaluate the overall survival of BLCA, which was then validated in the training cohort (P < 0.001, n = 396), two external validation cohorts (P < 0.05, n = 165; P < 0.001, n = 224), and local samples (P < 0.05, n = 10). We also downloaded the clinical information and gene expression matrices of other 32 different cancers from TCGA. The established model showed significant predictive value for the prognosis in 15 cancers (P < 0.05). The risk model could also serve as a promising predictor for immunotherapeutic response, which has been verified by the TIDE algorithm (P < 0.05), IMvigor210 dataset (P < 0.01, n = 298), and other two datasets correlated with immunotherapy (P < 0.05, n = 56; P = 0.17, n = 27). The TCGA dataset, in vitro cell experiments, and pan-cancer analysis displayed that the gene signature was associated with cisplatin sensitivity (P < 0.05). Overall, we proposed a novel immunosenescence-related gene signature to predict prognosis, immunotherapeutic response, and cisplatin sensitivity of BLCA, which were validated in different independent cohorts, local samples, and pan-cancer analyses.

学科与关键词

关键词
BACILLUS-CALMETTE-GUERINTUMORIDENTIFICATIONCHEMOTHERAPYVALIDATIONBIOMARKERCELLS
相关
加载中…
  • Construction and experimental validation of a B cell senescence-related gene signature to evaluate prognosis and immunotherapeutic sensitivity in bladder cancer
    Zhou, Ranran; Zhou, Jiawei; Muhuitijiang, Bahaerguli; Tan, Wanlong*FUNCTIONAL & INTEGRATIVE GENOMICS, 2023, 23(1): 3.被引 2
  • Construction and experimental validation of a macrophage cell senescence-related gene signature to evaluate the prognosis, immunotherapeutic sensitivity, and chemotherapy response in bladder cancer
    Jiang, Qijun; Zhou, Junhao; Chen, Qi; Huang, Yuliang; Yang, Cheng; Liu, Cundong*FUNCTIONAL & INTEGRATIVE GENOMICS, 2023, 23(3): 228.
  • Pan-cancer transcriptomic analysis identified six classes of immunosenescence genes revealed molecular links between aging, immune system and cancer
    Wang, Xinyue; Guo, Shuang; Zhou, Hanxiao; Sun, Yue; Gan, Jing; Zhang, Yakun; Zheng, Wen; Zhang, Caiyu; Wang, Peng; Zhi, Hui; Gao, Yue; Chen, Xiaofeng*; Ning, Shangwei*GENES AND IMMUNITY, 2023, 24(2): 81-91.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
DISEASE MARKERS
发表日期
2022-03-02
卷期
第 2022 卷
页码
2143892
DOI
10.1155/2022/2143892
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81772257]; Youth Cultivation Program of Southern Medical University [PY2018N076]; Medical Scientific Research Foundation of Guangdong Province [A2019557]

作者

  • Z

    Zhou, Ranran (第一作者)

    southern med univ

  • L

    Liang, Jingjing

    southern med univ

查看全部 6 位作者收起作者
  • T

    Tian, Hu

    southern med univ

  • C

    Chen, Qi

    southern med univ

  • Y

    Yang, Cheng

    southern med univ

  • L

    Liu, Cundong (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417